Enterprise Value
8.874B
Cash
713.7M
Avg Qtr Burn
-33.35M
Short % of Float
14.07%
Insider Ownership
16.61%
Institutional Own.
81.01%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|